$CLSH CLS Holdings Announces Record First Quarter Fiscal

New Post Public Reply Private Reply Replies (0) Message Board
Lee Adams
86
$CLSH CLS Holdings Announces Record First Quarter Fiscal 2020 Results

LAS VEGAS, NV, Oct. 15, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CLS Holdings USA, Inc. (OTCQB: CLSH, CSE: CLSH.CN) (“CLS” or the ''Company'' , a diversified cannabis company operating as Cannabis Life Sciences, is pleased to announce financial results for the first quarter ended August 31, 2019.

“First quarter results represent the beginning of what we expect to be a historic year for our company,” commented Andrew Glashow, President and COO of CLS Holdings. “These results continue to support and validate our strategy in Nevada, including at our Oasis Cannabis dispensary and within our City Trees line of branded products. Despite the number of records established during Q1 2020, we believe our operations have room to grow and we are excited about the opportunities going forward.”

Q1 2020 Highlights

● Record consolidated revenue of $2.9 million compared to $1.7 million in fiscal Q1 2019, an increase of $1.2 million or 72.7%.

● Record consolidated gross profit of $1.4 million, a 147.7% increase over the same period a year earlier.

● Record consolidated gross profit margin of 50.6% compared to 35.3% in fiscal Q1 2019.

● Consolidated net loss of $1.4 million or $0.01 per share compared to a net loss of $16.7 million or $0.23 per share in fiscal Q1 2019.

● Cash and cash equivalents of $5.9 million as of August 31, 2019.

● Record revenue from the Company’s Oasis Cannabis dispensary of $2.1 million, a 96.6% increase over fiscal Q1 2019 revenue of $1.1 million.

● Record Oasis Cannabis gross profit margin of 48.3% compared to 35.9% in fiscal Q1 2019.

● A 98.4% increase in dispensary customers, from 26,438 (294 average per day) in fiscal Q1 2019 to a record 52,448 (583 average per day) in fiscal Q1 2020.

● Record revenue per SF of $397 compared to $205 per SF during the same period a year earlier, an increase of 93.6%.

● Record revenue from the Company’s City Trees’ branded products division of $0.8 million compared to $0.6 million in fiscal Q1 2019, an increase of $0.2 million or 33.6%.

● Record City Trees branded products gross profit margin of 56.2% compared to 34.1% in fiscal Q1 2019.

Subsequent Second Quarter Events

● In Good Health, a licensed medical dispensary, which the Company has the exclusive right to acquire in January 2020, was granted on September 13, 2019 a final license for recreational use at its current location in Brockton, MA.

● Oasis Cannabis dispensary expansion expected to be completed in mid-November, increasing available retail space from 1,750 sf to 2,000 sf.

“We are incredibly pleased with our first quarter 2020 result,” commented Mr. Jeffrey Binder, Chairman and Chief Executive Officer of CLS Holdings. “To this end, we reported year over year quarterly revenue growth of 72.7%. We also dramatically increased gross margins from 35.3% in Q1 2019 to 50.6% in Q1 2020, in large part due to the implementation of new processes, the retention of additional skilled employees, and an improvement in inventory purchasing. As a result, I am proud to report that our Oasis Cannabis and City Trees subsidiaries are profitable on a stand-alone basis while our consolidated net loss stems primarily from those costs associated with being a publicly traded company and costs associated with the parent holding company.”

About CLS Holdings USA, Inc.

CLS Holdings USA, Inc. (CLSH) is a diversified cannabis company that acts as an integrated cannabis producer and retailer through its Oasis Cannabis subsidiaries in Nevada and plans to expand to other states. CLS stands for ''Cannabis Life Sciences,'' in recognition of the Company's patented proprietary method of extracting various cannabinoids from the marijuana plant and converting them into products with a higher level of quality and consistency. The Company's business model includes licensing operations, processing operations, processing facilities, sale of products, brand creation and consulting services.

http://www.clsholdingsinc.com

Twitter: @CLSHusa

About Oasis Cannabis

Oasis Cannabis has operated a cannabis dispensary in the Las Vegas market since dispensaries first opened in Nevada in 2015 and has been recognized as one of the top marijuana retailers in the state. Its location within walking distance to the Las Vegas Strip and Downtown Las Vegas in combination with its delivery service to residents allows it to efficiently serve both locals and tourists in the Las Vegas area. In February 2019, it was named ''Best Dispensary for Pot Pros'' by Desert Companion Magazine. In August 2017, the company commenced wholesale offerings of cannabis in Nevada with the launch of its City Trees brand of cannabis concentrates and cannabis-infused products.

http://oasiscannabis.com

About City Trees

Founded in 2017, City Trees is a Nevada-based cannabis cultivation, production and distribution company. Offering a wide variety of products with consistent results, City Trees is one the fastest growing wholesale companies in the industry. Its products are now available at 44 dispensaries.

https://citytrees.com

Disclaimer – Fiscal Q1 2019 Results of Operations

The Company acquired Oasis Cannabis and City Trees effective July 1, 2018. In order to provide comparable three- month quarterly periods for 2019 and 2018, the results of operations for the three months ended August 31, 2019 set forth herein include the results of the Oasis Cannabis dispensary and City Trees for the month of June 2018, when they were owned and operated by their former owners. The inclusion of this information should not be construed as an indication that the Company owned these entities during June 2018 but is only provided to assist readers in comparing current operating results with the prior operating results of these businesses.

Forward Looking Statements

This press release contains certain ''forward-looking information'' within the meaning of applicable Canadian securities legislation and ''forward-looking statements'' as that term is defined in the Private Securities Litigation Reform Act of 1995 (collectively, the ''forward-looking statements'' . These statements relate to anticipated future events, future results of operations or future financial performance, and anticipated growth, including the timing of anticipated construction and implementation of our expansion plan. In some cases, you can identify forward looking statements by terminology such as ''may,'' ''might,'' ''will,'' ''should,'' ''intends,'' ''expects,'' ''plans,'' ''goals,'' ''projects,'' ''anticipates,'' ''believes,'' ''estimates,'' ''predicts,'' ''potential,'' or ''continue'' or the negative of these terms or other comparable terminology. These forward-looking statements are only predictions, are uncertain and involve substantial known and unknown risks, uncertainties and other factors which may cause our actual results, levels of activity or performance to be materially different from any future results, levels of activity or performance expressed or implied by these forward-looking statements. We cannot guarantee future results, levels of activity or performance and we cannot guaranty that the proposed transactions described in this press release will occur. You should not place undue reliance on these forward-looking statements, which speak only as of the date that they were made. These cautionary statements should be considered together with any written or oral forward-looking statements that we may issue in the future. Except as required by applicable law, we do not intend to update any of the forward-looking statements to conform these statements to reflect actual results, later events or circumstances or to reflect the occurrence of unanticipated events. See CLS Holdings USA filings with the SEC and on its SEDAR profile at www.sedar.com for additional details.


Contact Information

Corporate:

Chairman and CEO

Jeff Binder

jeff@clsholdingsinc.com

888-438-9132

Investor Relations:

Torrey Hills Capital

Clay Chase

cc@sdthc.com

858-456-7300
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Amy Johnson Steps Up as GDIT President Amid Shifts

Updated Category News Views 24

A New Chapter for GDIT with a Veteran Leader Big shoes to fill? Nah, more like Amy Johnson was made for these shoes. Stepping up as president of General Dynamics Information Technology (GDIT) on November 3, she’s got 27 years of experience under her belt, all from General Dynamics' own backyard. This ain't her first rodeo. From tightrope-walking the perils of defense...

Continue Reading
Steady Income Boosts FHLBank Boston's Growth Q3 2026

Updated Category News Views 4

The Federal Home Loan Bank of Boston dropped their third-quarter results for 2026 like a hot smokestack, and let me tell you, it's a mixed bag of cautious optimism and steady progression. It's essentially proof that slow and steady might just win the race—or at least keep you in the running. Stable and Steady Headway Taking a peek under the hood, FHLBank Boston made a...

Continue Reading
Meissner's Big Move in Athens Expands Irradiation Capacity

Updated Category News Views 6

An Expansion That Matters Take a deep breath, folks, because what Meissner's pulling off in Athens ain't just small potatoes. The corporation's got a new X-ray irradiation facility under its belt, and they've taken the shovel to the ground for Phase 2 of their manufacturing campus. In an industry where being first is everything, doubling down on infrastructure proves...

Continue Reading
Dott's Q3 2026: Micromobility Growth Soars High

Updated Category News Views 7

Riding the Wave of Profit in Micromobility Sometimes all you need is a quick jolt of genius to turn the wheels of fortune. Dott seems to have hit that sweet spot in Q3 of 2026. Deploying 45,000 new vehicles wasn’t just a logistical feat; it was a calculated bet that paid off handsomely, bolstering their business to soaring heights. Performance that Packs a Punch The Q3...

Continue Reading
Hansa's Idefirix Shows Promise for Kidney Transplants

Updated Category News Views 4

Compelling Progress from Hansa Biopharma Y'know, navigating through the biotech jungle isn't for the faint-hearted. Hansa Biopharma's recent results with Idefirix could just be the beacon of hope for patients struggling on transplant lists. Announced at the ASN Kidney Week—a name that's got weight, by the way—these findings aren't just filling space. They're promising...

Continue Reading
Think Together Marks 20 Years of ASES Impact in CA

Updated Category News Views 40

Hands-on Learning: California's Bright Future Starts Here Who's ever thought a schoolyard's the same after three? Let me tell you, in California, it's staying alive and kicking, thanks to Think Together's whirlwind of celebrations for the After School Education and Safety (ASES) program. We're talking 450 schoolyard shindigs highlighting not just how far expanded learning...

Continue Reading
John Wong's Decade as Estate Planning Specialist

Updated Category News Views 29

One man's legacy isn’t built overnight, especially not in estate planning. And John L. Wong's decade of being a certified specialist by the State Bar of California tells a story of perseverance and grit. Now, at the helm of Modern Wealth Law in Irvine, California, Wong is a name that echoes through the halls of estate planning law with authority and respect. Creating...

Continue Reading
Lincoln Educational Faces Investor Lawsuit Over Revenue Drop

Updated Category News Views 46

Investors Face Rough Waters Okay, let’s dive into this latest mess at Lincoln Educational Services Corp. (NASDAQ:LINC). Things aren't smelling too rosy over at their headquarters. If you've got shares here, you’ll know what I mean. Back in early May, the folks running Lincoln threw a garden party talking up a 19.5% growth in student starts. Who wouldn’t get behind...

Continue Reading
Howard Hughes Joins S&P SmallCap 600, Arcosa Out

Updated Category News Views 25

Shakeup in the S&P SmallCap 600 It’s one of those days where something shifts in the market landscape—Howard Hughes Holdings Inc. (NYSE: HHH) is swaggering into the S&P SmallCap 600. Kicking off on October 28, it's got quite the entrance lined up. On the other end, Arcosa Inc. (NYSE: ACA) is making a hasty exit after getting scooped up by CRH plc (NYSE: CRH). For...

Continue Reading
Autoliv Sees Mixed Q3 2026 Amid Global Challenges

Updated Category News Views 6

An Uneven Road: Autoliv's Q3 2026 Chronicle You'd think by now everyone in the automotive game would have mastered the art of the pivot. Well, Autoliv seems to have gotten the memo for Q3 2026. Sales dipped slightly, yet their moves in Asia hint at a calculated gambit in a rough global landscape. Digging into the Numbers The financials were a mixed bag. Net sales huddled...

Continue Reading

Top 5 Most Recently Viewed Articles

Rubico Inc. Secures Time Charter Extensions to Enhance Revenue

Updated Category News Views 140

Rubico Inc. Expands Financial Outlook with Charter Extensions Rubico Inc. has made headlines recently as it announces the extension of time charters for both of its modern tanker vessels, supporting its steady growth in the shipping industry. Known for its eco-friendly, fuel-efficient tanker vessels, this move reflects the company's commitment to optimizing its...

Continue Reading
Exploring High-Yield Dividend Stocks in the Industrials Sector

Updated Category News Views 187

Investing in Dividend-Yielding Stocks During turbulent times in the financial markets, investors often seek refuge in dividend-yielding stocks. These stocks are typically from companies with strong free cash flows that reward their shareholders. In particular, high-yield dividend stocks can be an attractive option for those looking to generate income from their...

Continue Reading
Foventa Therapeutics: Spotlight on Diabetic Eye Treatment

Updated Category News Views 25

Foventa's Shift: From Science to Clinical Focus Well, isn't this a twist of fate? Exonate, the company that once thrived on cutting-edge science, is shedding its old skin and stepping into a new spotlight as Foventa Therapeutics. The old moniker is in the rearview, and now they're pledging to tackle non-proliferative diabetic retinopathy (NPDR) with a fresh angle—a...

Continue Reading
Elevating Patient Care: Viz.ai and Illuminate Unite Forces

Updated Category News Views 180

Innovative Partnership Between Viz.ai and Illuminate In a significant stride for patient care, Viz.ai has announced a collaborative expansion with Illuminate, a company renowned for its advancements in AI and natural language processing. This partnership aims to revolutionize the identification and monitoring of patients with cerebral aneurysms, facilitating timely...

Continue Reading
Trilogy Metals Shares Fiscal Insights and Project Developments

Updated Category News Views 328

Trilogy Metals Shares Fiscal Insights and Project Developments Trilogy Metals Inc. (NYSE American: TMQ) (TSX: TMQ), a notable player in metal exploration, recently announced its financial results for the third quarter ending August 31, 2025. The latest updates detail the company's fiscal health, progressive projects, and future outlook, revealing a net loss of $1.7...

Continue Reading